Tag: FDA biosimilars

FDA Listing for Biosimilars: How They Are Evaluated and Approved

Keith Ashcroft
|
December 25
|
1

The FDA doesn't rate biosimilars like generics - it rigorously evaluates them for molecular similarity, safety, and efficacy. Learn how the approval process works, why only 17 are interchangeable, and how they're changing patient access to biologics.